Company Data

Achilles Therapeutics plc

Ticker
ACHL
Current Price
$1.48
Market Cap
$60.8M
Price Target
Refer to Report
Volume
102.2K
52wk Range
$0.63 - $1.51
Advanced Market Data

Overview

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy